世界科学技术-中医药现代化2025，Vol.27Issue(1)：110-120,11.DOI:10.11842/wst.20230821004
基于多种工具评价冠心病中医临床实践指南的方法学质量
The Methodological Quality of TCM Clinical Practice Guidelines for Coronary Heart Disease was Evaluated Based on Multiple Tools
摘要
Abstract
Objective Based on the three tools of the AGREE Next Steps Consortium(AGREE Ⅱ),China Clinical Guidelines Evaluation System(AGREE-China)and Scientificity Transparency Applicability Rankings(STAR),the methodological quality of Chinese medicine clinical treatment guidelines for coronary heart disease published by domestic institutions was systematically evaluated.Methods Computer system retrieval of China National Knowledge Infrastructure(CNKI),WanFang Data,Chinese Science and Technology Journal Database(VIP),China Biology Medicine(CBM)and Yimai Tong,and collect clinical practice guidelines of traditional Chinese medicine for coronary heart disease issued by domestic institutions(including expert consensus).The search period was from the establishment of the database to December 31,2023.Results A total of 21 guidelines were included.AGREE Ⅱ recommended 13 for grade A and 8 for grade B.The approval-China review strongly recommends 12,weakly recommends 8,and does not recommend 1.The highest STAR rating is a 4.0 star recommendation and the lowest is a 1.5 star recommendation.Conclusions There are a large number of TCM diagnosis and treatment guidelines and expert consensus on coronary heart disease in China,but the quality is uneven.It is suggested that the future guideline formulation should pay attention to the evidence-based principle,promote the standardization and standardization of the guideline formulation,and improve the scientific and applicability of the guideline.关键词
冠心病/指南评价/AGREEⅡ/AGREE-China/STARKey words
Coronary heart disease/Guideline evaluation/AGREE Ⅱ/AGREE-China/STAR分类
医药卫生引用本文复制引用
于玉东,闫菁菁,李彬,李佳,于鹏真,梁贝贝,钟兰芳..基于多种工具评价冠心病中医临床实践指南的方法学质量[J].世界科学技术-中医药现代化,2025,27(1):110-120,11.基金项目
国家自然科学基金委员会面上项目(82074226):基于能量代谢研究人参总次苷干预冠心病心肌重构的作用及机制,负责人:李彬 （82074226）
河南省中医药科学研究专项(2023ZXZX1165):慢性心力衰竭中医临床研究结局指标的评价及应用研究,负责人:李彬 （2023ZXZX1165）
河南省中医药科学研究专项(2024ZY2013):基于多种工具评价心血管疾病中医临床实践指南/共识的质量和适用性评价,负责人:李彬. （2024ZY2013）
